Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

被引：0
|
作者：
Zhang, Chong [1 ]
Zeng, Da-Wu [2 ]
Cai, Da-Chuan [3 ]
Xue, Xiu-Lan [4 ]
Zhang, Ling-Yi [5 ]
Song, Bao-Jun [6 ]
Gao, Yu-Feng [7 ]
Huang, Yan [8 ]
Shang, Jia [9 ]
Wu, Xiao-Feng [10 ]
Zhang, Ying [11 ]
Jin, Hua [12 ]
Chen, Hui [13 ]
Tang, Hong [14 ]
Lu, Xiaobo [15 ]
Guan, Yujuan [16 ]
Min, Feng [17 ]
Xu, Liang [18 ]
Li, Gang [19 ]
Wang, Zhen-Guang [20 ]
Dou, Xiaoguang [1 ]
机构：
[1] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
[4] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China
[5] Lanzhou Univ, Hosp 2, Lanzhou, Peoples R China
[6] Sixth Peoples Hosp Fushun, Fushun, Peoples R China
[7] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China
[8] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China
[9] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China
[10] Sixth Peoples Hosp Shenyang, Shenyang, Peoples R China
[11] Dalian Publ Hlth Med Ctr, Dalian, Peoples R China
[12] Sixth Peoples Hosp Benxi, Benxi, Peoples R China
[13] Hepatobiliary Hosp Jilin, Changchun, Jilin, Peoples R China
[14] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[15] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China
[16] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China
[17] Army Seventy Three Army Hosp, Beijing, Peoples R China
[18] Tianjin Second Peoples Hosp, Tianjin, Peoples R China
[19] Liaohe Oilfield Gen Hosp, Panjin, Peoples R China
[20] Anshan City Hosp Infect Dis, Anshan, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-193
引用
收藏
页码：S1165 / S1166
页数：2
相关论文
共 50 条
  • [41] The Optimizing Treatment of Peg Interferon Alfa in Hbeag Negative Chronic Hepatitis B Patients with Low Level HBsAg: A Multicenter Real World Study (Interferon Cure Study, I CURE Study)
    Gao, Zhiliang
    Zhu, Xiang
    Lin, Bingliang
    Yi, Jianhua
    Gao, Wenjun
    Chen, Youming
    Xie, Dongying
    Deng, Hong
    Lin, Chaoshuang
    You, Jing
    Zhang, Chunlan
    Xie, Qifeng
    Ye, Yinong
    Zhang, Xiaohong
    Peng, Liang
    Gan, Weiqiang
    Zhao, Qiyi
    HEPATOLOGY, 2018, 68 : 246A - 246A
  • [42] Leukocyte interferon-alpha and ribavirin in combination vs recombinant interferon alpha-2b and ribavirin combination for treatment of naive patients with chronic hepatitis C: A multicenter Italian study.
    Barbarini, G
    Pellicelli, A
    Fruttaldo, L
    Bacca, D
    Babudieri, S
    Torre, D
    Francavilla, R
    Rizzo, G
    Annese, M
    Grimaldi, M
    Zaccarini, P
    Wassermann, A
    Barbaro, G
    HEPATOLOGY, 2001, 34 (04) : 593A - 593A
  • [43] A viral kinetic study using pegylated interferon alpha 2b and lamivudine in naive patients with HBeAg(-)/HBV-DNA(+) chronic hepatitis B: Preliminary results
    Sypsa, V
    Tassopoulos, NC
    Chrysagis, D
    Mimidis, K
    Vassiliadis, T
    Raptopoulou, M
    Ketikoglou, I
    Haida, C
    Paraskevis, D
    Lafleur, F
    Hatzakis, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 94 - 94
  • [44] Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naive patients with chronic hepatitis B: a multicenter real-life study
    Batirel, Ayse
    Guclu, Ertugrul
    Arslan, Ferhat
    Kocak, Funda
    Karabay, Oguz
    Ozer, Serdar
    Turanli, Munevver
    Mert, Ali
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 28 : 153 - 159
  • [45] Analysis of the relationship of physical symptom development and depression in patients with chronic hepatitis C on pegylated interferon alpha-2b and ribavirin therapy.
    Levine, CD
    Ghalib, RH
    McClelland, T
    Sorguc, N
    HEPATOLOGY, 2001, 34 (04) : 593A - 593A
  • [46] A high functional cure rate was induced by pegylated interferon alpha-2b treatment in postpartum hepatitis B e antigen-negative women with chronic hepatitis B virus infection: an exploratory study
    Zhong, Wenting
    Yan, Lanzhi
    Zhu, Yage
    Shi, Lei
    He, Yingli
    Chen, Tianyan
    Zheng, Jie
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [47] SELECT-2 Clinical Trial Assessing the Efficacy and Saftey of Controlled-Release Interferon Alpha-2B (CR2b)+Ribavirin (RBV) Versus Pegylated Interferon Alpha-2B (Peg2b)+RBV in Treatment-NaiVE Genotype-1 (G1) Hepatitis C
    Younossi, Zobair M.
    Lawitz, Eric J.
    Krastev, Zahary
    Rigney, Amy
    Tchernev, Konstantin
    Takov, Dimitar
    Ghalib, Reem H.
    Long, Walker A.
    GASTROENTEROLOGY, 2011, 140 (05) : S942 - S942
  • [48] Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT
    Al-Ali, Jaber
    Siddique, Iqbal
    Varghese, Rosh
    Hasan, Fuad
    ANNALS OF HEPATOLOGY, 2012, 11 (02) : 186 - 193
  • [49] A viral kinetic study using pegylated interferon alpha 2b and lamivudine in naive patients with hepatitis B e antigen negative/hepatitis B virus DNA-positive chronic hepatitis B.
    Sypsa, V
    Tassopoulos, NC
    Chrysagis, D
    Raptopoulou, M
    Ketikoglou, I
    Vassiliadis, T
    Haida, C
    Paraskevis, D
    Lafleur, F
    Hatzakis, A
    HEPATOLOGY, 2001, 34 (04) : 317A - 317A
  • [50] Interim analysis of randomized, controlled trial comparing thymosin alpha-1 plus pegylated interferon alpha-2a combination therapy with pegylated interferon alpha-2a monotherapy in HBeAG-positive chronic hepatitis B
    Kim, W.
    Yoon, J. H.
    Lee, Y. J.
    Park, S. J.
    Kim, B. H.
    Lee, J. H.
    Yang, J. I.
    Myung, S. J.
    Km, D. H.
    Kim, Y. J.
    Lee, H. S.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S258 - S258
12345